Subconjunctival bevacizumab injection for corneal neovascularization.
about
Effects of topical and subconjunctival bevacizumab in high-risk corneal transplant survivalCorneal neovascularization: an anti-VEGF therapy review.Effects of estrogen replacement therapy on apoptosis and vascular endothelial growth factor expression in ocular surface epithelial cells: An experimental study.Topical bevacizumab in the treatment of corneal neovascularization: results of a prospective, open-label, noncomparative study.Pterygia: pathogenesis and the role of subconjunctival bevacizumab in treatment.Corneal transparency: genesis, maintenance and dysfunctionEffect of intravitreal injection of bevacizumab-chitosan nanoparticles on retina of diabetic rats.Corneal Allograft Rejection: Immunopathogenesis to Therapeutics.Novel aspects of corneal angiogenic and lymphangiogenic privilege.Emerging techniques to treat corneal neovascularisationThe association between corneal neovascularization and visual acuity: a systematic review.Boston keratoprosthesis restoring vision in an unusual case of end-stage limbal stem cell deficiency following exposure to Euphorbia latex.Transplantation of PEDF-transfected pigment epithelial cells inhibits corneal neovascularization in a rabbit model.Vascular endothelial growth factor gene polymorphism and protein expression in the pathogenesis of pterygium.Recent drug therapies for corneal neovascularization.Corneal penetration of topical and subconjunctival bevacizumab.Effect of subconjunctival and intraocular bevacizumab injections on corneal neovascularization in a mouse model.Prevention of corneal neovascularization: comparison of different doses of subconjunctival bevacizumab with its topical form in experimental rats.The effect of different doses of subconjunctival bevacizumab injection on corneal neovascularization.Treatment of corneal neovascularization in ocular chemical injury with an off-label use of subconjunctival bevacizumab: a case reportEfficacy of topical bevacizumab in high-risk corneal transplant survival.Corneal endothelial safety following subconjunctival and intrastromal injection of bevacizumab for corneal neovascularization.The anti-inflammatory effect of subconjunctival bevacizumab on chemically burned rat corneas.Effectiveness of photodynamic therapy with verteporfin combined with intrastromal bevacizumab for corneal neovascularization in Stevens-Johnson syndrome.
P2860
Q33845555-50080E57-69B9-4C70-B42B-39525EDC1A9DQ34641522-9240112A-FE0B-4545-87C8-858820439129Q35924238-FF329C8E-862C-4A6E-AA71-3ACFC85EA01DQ37244781-169A3F3B-CBF5-4BCA-8677-579F4A74455FQ37479346-7A58309F-A990-4975-A464-FCCABA8F413FQ37500924-4BB9962B-4A75-4CDB-8CC6-C65D1FBADB38Q37629986-9AB8A80F-83CA-44D6-9C64-AAB46DA4D9E6Q37638300-6E91EC44-AE34-406D-ACBE-2B946FCECE1FQ37681157-B154B64B-2780-4EE6-908C-C6158073BF2AQ37943247-CA946564-5313-4D0E-ADAF-507504C797BEQ37959022-F0EDF900-05F8-42AE-BDA7-6D18E215EDD9Q37978201-78212CF6-38DC-4DA7-91EA-235F84B5EA1CQ38908590-FE5BAA6A-20A9-48F7-88C4-09D04D755B80Q39079325-26281372-1C7E-4934-9BA5-397A9F589A4EQ39295602-88F83DCF-A236-4561-97BA-721FC2B374BFQ39589760-206F3C2C-2EE8-459A-BDEB-8C2EEF94F92DQ39918424-67107022-4EAE-49CD-AF7D-2C0FD163C6AFQ39965612-646317B0-CF90-460D-AA16-D4C3B9A5337BQ40091988-384165E7-AF07-46A6-89E0-DC6B5A161DDCQ42563919-4FABB58B-0A5E-4904-B5D7-A1BE1AFD37CBQ42933253-CF9A29B7-2323-43E8-8F7D-9DE14EFA485AQ45359325-86907F3B-4E18-4CB2-8CF6-124966478CEDQ46121010-9315505E-DE5F-4B7A-B943-ED7C07631113Q48095945-9F2A3D08-9C84-468C-A0AF-82E5D372FE1A
P2860
Subconjunctival bevacizumab injection for corneal neovascularization.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Subconjunctival bevacizumab injection for corneal neovascularization.
@en
Subconjunctival bevacizumab injection for corneal neovascularization.
@nl
type
label
Subconjunctival bevacizumab injection for corneal neovascularization.
@en
Subconjunctival bevacizumab injection for corneal neovascularization.
@nl
prefLabel
Subconjunctival bevacizumab injection for corneal neovascularization.
@en
Subconjunctival bevacizumab injection for corneal neovascularization.
@nl
P2093
P1433
P1476
Subconjunctival bevacizumab injection for corneal neovascularization
@en
P2093
Allan Slomovic
David Rootman
Irit Bahar
Penny McAllum
P304
P356
10.1097/ICO.0B013E318159019F
P577
2008-02-01T00:00:00Z